Kirkland, Wash.-based Kestra Medical Technologies raised $202 million in its initial public offering, pricing shares at $17. Previously: Kestra Medical Technologies, maker of wearable cardiac devices, files for IPO
Kestra Medical Technologies, a Kirkland, Wash.-based company selling cardiac monitoring and therapeutic devices, filed for an initial public offering on Monday. The company’s revenue more than tripled from $7.6 million… Read More
Seattle’s tech industry is in an IPO drought. Not a single tech company from the region went public via traditional initial public offering over the past two years, according to… Read More
RealWear, a Vancouver, Wash.-based company that sells industrial hands-free wearable “assisted reality” headsets, is going public via a SPAC deal with Seattle-based Cascadia Capital. The deal, announced Monday, will value… Read More
After startup exit activity took a nose dive in 2022 amid inflation, rising interest rates, and other macroeconomic forces, some tech analysts are predicting public listing and acquisitions to pick… Read More
It’s getting harder for an early-stage company to find a buyer. The exit value for U.S. venture capital-backed startups in the second quarter was the lowest it’s been in more… Read More
Rivian, the electric vehicle maker with substantial backing from Amazon, is arriving with a roar in its public debut on the Nasdaq exchange today. Rivian set its IPO price at… Read More
It’s been a heck of a startup journey for Remitly. The latest chapter begins Thursday when the mobile remittance company starts trading on the NASDAQ, marking a key milestone for… Read More
Remitly will be valued at nearly $7 billion when it goes public on Thursday. The Seattle company priced shares at $43 on Wednesday evening, above its expected range of $38-to-$42,… Read More
Remitly set terms for its IPO on Tuesday. The fintech company expects to raise $284.6 million, or $332.6 million if underwriters purchase additional shares. It will be one of the… Read More
Seattle-based money remittance company Remitly disclosed key financial results on Monday afternoon in its Form S-1 registration statement, a key milestone toward becoming a publicly traded company. Remitly generated $257… Read More
Rivian, the electric vehicle maker that has attracted huge funding from Amazon and others, announced Friday that it plans to go public, and one report values the company at roughly… Read More
It started as a simple pitch at a Seattle hackathon for a marketplace to facilitate matches between pet owners and sitters. Now, a decade later, Rover is a publicly traded… Read More
Icosavax is having quite the debut as Washington state’s newest public company. Shares of the Seattle-based biotech firm surged more than 200% on its first day of trading Thursday. Icosavax… Read More
Shares of Absci surged more than 30% on Thursday as the Vancouver, Wash.-based biotech company made its debut as a public company. Absci priced its stock at $16 per share… Read More
Eliem Therapeutics, a clinical stage biotech company generating therapies for pain, depression and other nervous-system related conditions, has filed to go public via an IPO. The company’s filing with the… Read More
Absci, a Vancouver, Wash.-based company developing technologies to accelerate the process of drug discovery, announced today that it plans to go public via an IPO. The company’s platform is built… Read More
Remitly is going public. The mobile remittance company said Wednesday it confidentially submitted a draft registration statement with the SEC for its proposed IPO. Reuters reported last month that Remitly… Read More
The news: Seattle-based biotech company Impel NeuroPharma raised $80 million in its initial public offering and will begin trading on the NASDAQ Friday under the ticker IMPL. It is the… Read More
Seattle-based biotech company Impel NeuroPharma is set to go public. The company, which develops drugs for central nervous system disorders such as migraines and Parkinson’s, submitted paperwork on Friday for… Read More
A little more than two years ago, days before Qualtrics was set to go public, SAP swooped in with a deal to acquire the experience management technology company for $8… Read More
Silverback Therapeutics will raise $241.5 million as the Seattle biotech company goes public Friday. Silverback priced its IPO on Thursday evening at $21 per share, which exceeded the high end… Read More
Silverback Therapeutics plans to raise up to $151.8 million in its initial public offering, the Seattle-based company said Monday in an updated IPO filing. The biotech firm will aim to… Read More
Heavily-funded real estate brokerage Compass hired Morgan Stanley and Goldman Sachs to lead an initial public offering next year, according to a report in Bloomberg News citing a person with… Read More
Laird Superfood stock doubled Wednesday before ending up at $40 per share on the first day of trading for the Sisters, Ore.-based company. The startup, co-founded by legendary surfer Laird… Read More
More than 5 million Americans have Alzheimer’s disease, and the number is projected to rise to nearly 14 million by 2050. The disease is the sixth-leading cause of death in… Read More
Athira Pharma will raise at least $204 million as the Seattle biotech startup becomes a public company on Friday. Athira priced its IPO on Thursday evening at $17 per share,… Read More
Snowflake came out with a bang in its public debut, raising $3.4 billion in the largest software IPO ever. The data warehousing company opened at $245/share after pricing its IPO… Read More
Athira Pharma plans to price its stock at $15 to $17 per share and raise up to $170 million in its initial public offering. The Seattle biotech filed updated IPO… Read More
Cancer detection startup Grail today filed to go public as the Silicon Valley biotech aims to raise more funding for its blood test. The company’s backers include Microsoft co-founder Bill… Read More
